Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients
Status
Conditions
Details and patient eligibility
About
This is an observational study examining serum markers in patients who are undergoing either a cadaveric liver transplant or a living related liver transplant.
Full description
The Departments of Anesthesiology are conducting an observational trial of markers in the serum of patients who are undergoing liver transplantation surgery. This study will utilize the biological markers, trimethylamine-N-oxide (TMAO), NGAL, and cystatin-C, sensitive markers of renal medullary injury in the blood and allantoin, a marker of oxidative stress as indicators of renal injury in a kidney during liver transplants. It is hypothesized that: (1) these markers are less pronounced in living donor liver transplant recipient patients than in cadaveric liver transplant recipients, and (2) these markers are less pronounced in cadaveric liver transplant recipients in which a "piggy-back" technique was used versus recipients in which a total venous occlusion technique was used. This study will be done in a multi-center format, along with researchers at UCSF
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- American Society of Anesthesiologists (ASA) Class I-V.
- Patient is undergoing elective Liver Transplant Surgery.
- Patient is an adult, 18 years old or older.
Exclusion criteria
- Patients < 18 Years of Age
- Patients who are pregnant
Trial design
20 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal